Pharma Reviews: India is said to block Fosun's $1.3 billion Gland Pharma acquisition

India is poised to reject Shanghai Fosun Pharmaceutical Group Co.'s proposed $1.3 billion takeover of an Indian drugmaker, according to people ...
Read more: India is said to block Fosun's $1.3 billion Gland Pharma acquisition